John P. Neoptolemos
Heidelberg, BW, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 212 publications
GATA6 immunohistochemistry and prognosis after surgical resection of pancreatic adenocarcinoma: results from the ESPAC-4 trial.
Journal: ESMO gastrointestinal oncology
Published: February 06, 2026
Clinical implications and biomarkers in the PACT-21 CASSANDRA trial.
Journal: Lancet (London, England)
Published: November 26, 2025
The PREOPANC-2 trial in resectable and borderline resectable pancreatic cancer.
Journal: The Lancet. Oncology
Published: September 25, 2025
The International Study Group for Pancreatic Surgery (ISGPS) Definition and Classification of Postpancreatectomy Mortality.
Journal: Annals of surgery
Published: September 17, 2025
Neoadjuvant therapy for left-sided resectable pancreatic ductal adenocarcinoma: evidence-based shift or premature extrapolation?
Journal: Hepatobiliary surgery and nutrition
Published: August 10, 2025
New implications from long-term outcomes of perioperative therapy in resectable pancreatic cancer.
Journal: British journal of cancer
Published: July 16, 2025
Oxaliplatin resistance in pancreatic ductal adenocarcinoma is non‑significantly mediated by diminished drug uptake but is highly linked to a poor apoptotic response to the cytotoxic threat.
Journal: Oncology reports
Published: June 26, 2025
Reply to: Adjuvant Treatment Options and Modalities in Pancreatic Adenocarcinoma: Insights From ESPAC4.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: March 31, 2025
NQO1 as a predictor of response to adjuvant GemCap treatment for pancreatic cancer.
Journal: Journal of the National Cancer Institute
Published: February 17, 2025
Letter to the Editor: The duodenum-preserving head resections for chronic pancreatitis: Beger, Livocado and Pottakkat.
Journal: Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.]
Published: February 04, 2025
Estimating treatment effects using parametric models as counter-factual evidence.
Journal: BMC medical research methodology
Published: January 20, 2025
Pancreatic Adenocarcinoma: Long-Term Outcomes of Adjuvant Therapy in the ESPAC4 Phase III Trial.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: December 05, 2024
Last Updated: 09/26/2026